ES2182827T3 - Gen del virus corona canino y usos del mismo. - Google Patents

Gen del virus corona canino y usos del mismo.

Info

Publication number
ES2182827T3
ES2182827T3 ES93911346T ES93911346T ES2182827T3 ES 2182827 T3 ES2182827 T3 ES 2182827T3 ES 93911346 T ES93911346 T ES 93911346T ES 93911346 T ES93911346 T ES 93911346T ES 2182827 T3 ES2182827 T3 ES 2182827T3
Authority
ES
Spain
Prior art keywords
gene
same
crown virus
canine
canine crown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93911346T
Other languages
English (en)
Inventor
Timothy J Miller
Sharon Klepfer
Albert Paul Reed
Elaine V Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2182827T3 publication Critical patent/ES2182827T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTAN LAS SECUENCIAS DE AMINOACIDOS Y DE NUCLEOTIDOS DE UN GEN DE ESPIGAS DE CCV Y COMPOSICIONES QUE CONTIENEN UNO O MAS FRAGMENTOS DEL GEN DE ESPIGAS PARA LA PROFILAXIS, DIAGNOSTICO Y TRATAMIENTO DE INFECCIONES PROVOCADAS POR EL CCV.
ES93911346T 1992-05-08 1993-05-07 Gen del virus corona canino y usos del mismo. Expired - Lifetime ES2182827T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88019492A 1992-05-08 1992-05-08

Publications (1)

Publication Number Publication Date
ES2182827T3 true ES2182827T3 (es) 2003-03-16

Family

ID=25375695

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93911346T Expired - Lifetime ES2182827T3 (es) 1992-05-08 1993-05-07 Gen del virus corona canino y usos del mismo.

Country Status (10)

Country Link
EP (1) EP0640098B1 (es)
JP (1) JP3245169B2 (es)
AT (1) ATE225805T1 (es)
AU (1) AU670092B2 (es)
CA (1) CA2135200C (es)
DE (1) DE69332375T2 (es)
DK (1) DK0640098T3 (es)
ES (1) ES2182827T3 (es)
PT (1) PT640098E (es)
WO (1) WO1993023423A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023421A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Universal coronavirus vaccine
GB2316681B (en) * 1993-09-16 1998-04-15 Dimminaco Ag Sa Ltd Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
FR2828405B1 (fr) 2001-08-09 2005-06-24 Virbac Sa Vaccin anti-coronavirus
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
CN113583096B (zh) * 2020-05-01 2023-06-30 清华大学 SARS-CoV-2 Spike蛋白受体结合域二聚体及其应用
CN112079906B (zh) * 2020-07-15 2022-11-04 张影 一种新型冠状病毒刺突蛋白、相关生物材料及其应用、检测试纸和检测试剂盒
CN113945714B (zh) * 2020-07-16 2023-01-31 南京蓬勃生物科技有限公司 新型冠状病毒中和抗体类药物中和能力的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264979A1 (en) * 1986-09-05 1988-04-27 Duphar International Research B.V New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines
HUT45559A (en) * 1987-01-16 1988-07-28 Duphar Int Res Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
ES2213743T3 (es) * 1991-04-25 2004-09-01 Akzo Nobel N.V. Vacuna de subunidad de coronavirus canino.
EP0524672A1 (en) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV vaccine
WO1993023421A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Universal coronavirus vaccine

Also Published As

Publication number Publication date
JP3245169B2 (ja) 2002-01-07
ATE225805T1 (de) 2002-10-15
PT640098E (pt) 2003-01-31
WO1993023423A1 (en) 1993-11-25
EP0640098A4 (en) 1997-01-02
CA2135200C (en) 2001-03-27
EP0640098B1 (en) 2002-10-09
AU4251593A (en) 1993-12-13
EP0640098A1 (en) 1995-03-01
DK0640098T3 (da) 2002-10-28
AU670092B2 (en) 1996-07-04
DE69332375T2 (de) 2003-02-13
DE69332375D1 (de) 2002-11-14
CA2135200A1 (en) 1993-11-25
JPH07508421A (ja) 1995-09-21

Similar Documents

Publication Publication Date Title
ES2120036T3 (es) Virus recombinantes y su utilizacion en terapia genetica.
ES2167717T3 (es) Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos.
ES2104717T3 (es) Oligonucleotidos para modular los efectos de las infecciones por citomegalovirus.
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
DE69519521D1 (de) Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ES2086997T3 (es) Oligonucleotido-alquilfosfonatos y -alquilfosfonotioatos.
BR0305426A (pt) Compostos inibidores de ns5b polimerase de hcv, bem como composição farmacêutica compreendendo os mesmos
HUP9903822A2 (hu) Polinukleotid-vakcinakészítmény sertések szaporodásbiológiai és légzőszervi kórképei ellen
ATE114169T1 (de) Morphogenetisches knochenprotein.
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
BR0311126A (pt) Composições e método para tratar infecção em gado bovino e em suìnos
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
BR9812339A (pt) Processo para branquear os dentes, e, composição de higiene oral para branqueamento do dente
ES2010538A6 (es) Procedimiento para la preparacion de un gen sintetico.
ES2096262T3 (es) Nuevas cyclosporins modificadas en la posicion 1.
ES2103928T3 (es) Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
AR016295A1 (es) Antigeno de superficies y proteinas utiles de composiciones para el diagnostico y prevencion de la enfermedad de lyme
ES2151506T3 (es) Moleculas de adn recombinante que codifican enzimas aminopeptidasa y su uso en la preparacion de vacunas contra infecciones por helmintos.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
PA8446301A1 (es) 2-amino-6-(4-fenoxi-2-sustituido)-piridinas sustituidas
ES2055922T3 (es) Vacunas para la proteccion ante infecciones por virus hiv, procedimiento para su preparacion y su uso como agente de diagnostico e inmunoterapeutico.